HomeINM • NASDAQ
add
InMed Pharmaceuticals Inc
Previous close
$1.31
Day range
$1.29 - $1.34
Year range
$1.13 - $8.27
Market cap
3.70M USD
Avg Volume
609.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.12M | -11.43% |
Operating expense | 2.17M | -3.60% |
Net income | -1.73M | -2.92% |
Net profit margin | -154.17 | -16.20% |
Earnings per share | — | — |
EBITDA | -1.71M | -0.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.37M | 66.61% |
Total assets | 13.36M | 27.67% |
Total liabilities | 1.77M | -14.46% |
Total equity | 11.59M | — |
Shares outstanding | 3.95M | — |
Price to book | 0.45 | — |
Return on assets | -30.47% | — |
Return on capital | -33.39% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.73M | -2.92% |
Cash from operations | -1.61M | 12.00% |
Cash from investing | 0.00 | — |
Cash from financing | -137.18K | -116.37% |
Net change in cash | -1.74M | -76.50% |
Free cash flow | -877.48K | 23.27% |
About
Founded
1981
Headquarters
Website
Employees
13
